Christian Hobeika, Maxime Ronot, Boris Guiu, Giovanna Ferraioli, Hiroko Iijima, Toshifumi Tada, Dong Ho Lee, Hidekatsu Kuroda, Young Hwan Lee, Jeong Min Lee, So Yeon Kim, Christophe Cassinotto, Laura Maiocchi, Ambra Raimondi, Takashi Nishimura, Takashi Kumada, Eun Young Kwon, Jong Keon Jang, Jean-Michel Correas, Dominique Valla, Valérie Vilgrain, Marco Dioguardi Burgio
BACKGROUND AND RATIONALE: Non-invasive tools assessing steatosis, such as ultrasonography-based 2D-attenuation imaging (ATI), are needed to tackle the worldwide burden of steatotic liver disease. This one-stage individual patient data (IPD) meta-analysis aimed to create an ATI-based steatosis grading system. MAIN RESULTS: A systematic review (EMBASE+MEDLINE, 2018-2022) identified studies, including patients with histologically or MRI-PDFF-verified ATI for grading steatosis (S0 to S3)...
April 23, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases